Clinical relevancy of the levothyroxine-continuous enteral nutrition interaction

Nutrition in Clinical Practice

Volumn 25, Issue 6, 2010, Pages 646-652

  Dickerson, Roland N ^a   Maish III, George O ^a   Minard, Gayle ^a   Brown, Rex O ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

enteral nutrition; food drug interactions; hypothyroidism; thyroxine

Indexed keywords

LEVOTHYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENTERIC FEEDING; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; OVERT HYPOTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION TEST;

ADULT; AGED; AGED, 80 AND OVER; ENTERAL NUTRITION; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROXINE;

EID: 78650468880     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533610385701     Document Type: Article

References (45)

1. IMS Health. IMS National Prescription Audit™. Norwalk, CT: IMS Health ; 2008.
2. Mandel SJ, Brent GA, Larsen PR Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993 ; 119: 492-502.
3. Wenzel KW, Kirschsieper HE Aspects of the absorption of oral L-thyroxine in normal man. Metabolism. 1977 ; 26: 1-8.
4. Singh N., Singh PN, Hershman JM Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000 ; 283: 2822-2825.
5. Mersebach H., Rasmussen AK, Kirkegaard L., Feldt-Rasmussen U. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol. 1999 ; 84: 107-109.
6. Liel Y., Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994 ; 97: 363-365.
7. Campbell NR, Hasinoff BB, Stalts H., Rao B., Wong NC Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992 ; 117: 1010-1013.
8. Diskin CJ, Stokes TJ, Dansby LM, Radcliff L., Carter TB Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement. Int Urol Nephrol. 2007 ; 39: 599-602.
9. John-Kalarickal J., Pearlman G., Carlson HE New medications which decrease levothyroxine absorption. Thyroid. 2007 ; 17: 763-765.
10. Sherman SI, Tielens ET, Ladenson PW Sucralfate causes malabsorption of L-thyroxine. Am J Med. 1994 ; 96: 531-535.
11. Kaykhaei MA, Shams M., Sadegholvad A., Dabbaghmanesh MH, Omrani GR Low doses of cholestyramine in the treatment of hyperthyroidism. Endocrine. 2008 ; 34: 52-55.
12. Liao WK, Kuo SW, Huang WS, Jeng CY, Fuh MMT. Changes of thyroid hormone levels in patients with Grave's hyperthyroidism receiving cholestyramine adjunctive therapy. J Med Sci. 1994 ; 15: 163-170.
13. Shakir KM, Michaels RD, Hays JH, Potter BB The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism. Ann Intern Med. 1993 ; 118: 112-113.
14. Siraj ES, Gupta MK, Reddy SS Raloxifene causing malabsorption of levothyroxine. Arch Intern Med. 2003 ; 163: 1367-1370.
15. Bell DS, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract. 2001 ; 7: 193-194.
16. Jabbar MA, Larrea J., Shaw RA Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll Nutr. 1997 ; 16: 280-282.
17. Chiu AC, Sherman SI Effects of pharmacological fiber supplements on levothyroxine absorption. Thyroid. 1998 ; 8: 667-671.
18. Liel Y., Harman-Boehm I., Shany S. Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab. 1996 ; 81: 857-859.
19. Mechanick JI, Brett EM Nutrition support of the chronically critically ill patient. Crit Care Clin. 2002 ; 18: 597-618.
20. Choban PS, Dickerson RN Morbid obesity and nutrition support: is bigger different ? Nutr Clin Pract. 2005 ; 20: 480-487.
21. Dickerson RN, Boschert KJ, Kudsk KA, Brown RO Hypocaloric enteral tube feeding in critically ill obese patients. Nutrition. 2002 ; 18: 241-246.
22. Santini F., Pinchera A., Marsili A., et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2005 ; 90: 124-127.
23. Roberts CG, Ladenson PW Hypothyroidism. Lancet. 2004 ; 363: 793-803.
24. Surks MI, Ortiz E., Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 ; 291: 228-238.
25. Basaria S., Cooper DS Amiodarone and the thyroid. Am J Med. 2005 ; 118: 706-714.
26. Northcutt RC, Stiel JN, Hollifield JW, Stant EG Jr. The influence of cholestyramine on thyroxine absorption. JAMA. 1969 ; 208: 1857-1861.
27. Stockigt JR, Topliss DJ Assessment of thyroid function during high-dosage furosemide therapy. Arch Intern Med. 1989 ; 149: 973.
28. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med. 1995 ; 333: 1688-1694.
29. Dickerson RN, Mitchell JN, Morgan LM, et al. Disparate response to metoclopramide therapy for gastric feeding intolerance in trauma patients with and without traumatic brain injury. JPEN J Parenter Enteral Nutr. 2009 ; 33: 646-655.
30. Lindsey KA, Brown RO, Maish GO III, Croce MA, Minard G., Dickerson RN Influence of traumatic brain injury on potassium and phosphorus homeostasis in critically ill multiple trauma patients. Nutrition. 2010 ; 26: 784-790.
31. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993 ; 43: 107-109.
32. Bello G., Pennisi MA, Montini L., et al. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. Chest. 2009 ; 135: 1448-1454.
33. Carr D., McLeod DT, Parry G., Thornes HM Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf). 1988 ; 28: 325-333.
34. Benvenga S., Bartolone L., Squadrito S., Lo Giudice F., Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995 ; 5: 249-253.
35. Hays MT Localization of human thyroxine absorption. Thyroid. 1991 ; 1: 241-248.
36. Smyrniotis V., Vaos N., Arkadopoulos N., Kostopanagiotou G., Theodoraki K., Lambrou A. Severe hypothyroidism in patients dependent on prolonged thyroxine infusion through a jejunostomy. Clin Nutr. 2000 ; 19: 65-67.
37. Munoz-Torres M., Varsavsky M., Alonso G. Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid. 2006 ; 16: 1171-1173.
38. Chorazy PA, Himelhoch S., Hopwood NJ, Greger NG, Postellon DC Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics. 1995 ; 96: 148-150.
39. Dickerson RN, Garmon WM, Kuhl DA, Minard G., Brown RO Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. Pharmacotherapy. 2008 ; 28: 308-313.
40. Hays MT Thyroid hormone and the gut. Endocr Res. 1988 ; 14: 203-224.
41. Manessis A., Lascher S., Bukberg P., et al. Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastrostomy tubes. JPEN J Parenter Enteral Nutr. 2008 ; 32: 197-200.
42. Combs GF Jr, Midthune DN, Patterson KY, et al. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr. 2009 ; 89: 1808-1814.
43. Kandhro GA, Kazi TG, Afridi HI, et al. Effect of zinc supplementation on the zinc level in serum and urine and their relation to thyroid hormone profile in male and female goitrous patients. Clin Nutr. 2009 ; 28: 162-168.
44. Morgan LM, Dickerson RN, Alexander KH, Brown RO, Minard G. Factors causing interrupted delivery of enteral nutrition in trauma intensive care unit patients. Nutr Clin Pract. 2004 ; 19: 511-517.
45. Vriesendorp TM, van Santen S., DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006 ; 34: 96-101. (Pubitemid 43032385)